Trexquant Investment’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Trexquant Investment’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,587	Closed	-$256K	–	1281
2016 Q3	$256K	Buy	+28,587	New	+$203K	0.06%	544
2016 Q1	–	Sell	-114,326	Closed	-$594K	–	1392
2015 Q4	$594K	Buy	+114,326	New	+$663K	0.05%	610
2015 Q3	–	Sell	-55,600	Closed	-$877K	–	1491
2015 Q2	$877K	Buy	55,600 +2,326	+4%	+$28.3K	0.1%	379
2015 Q1	$579K	Buy	+53,274	New	+$544K	0.06%	633

Trexquant Investment's RPTP Position: Q4 2016 in Review

Trexquant Investment sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 28,587 shares — an estimated $256K sold.

Trexquant Investment first reported a position in RPTP in Q1 2015 and held it in 4 quarters. The position peaked at $877K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Trexquant Investment reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Trexquant Investment sold 28,587 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $256K.
Trexquant Investment first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2015 and held it in 4 quarters.
Trexquant Investment's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $877K in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Trexquant Investment's 13F filing for Q4 2016, filed 10 Feb 2017.